215 related articles for article (PubMed ID: 33370315)
1. Rapid and robust patterns of spontaneous locomotor deficits in mouse models of Huntington's disease.
Heikkinen T; Bragge T; Bhattarai N; Parkkari T; Puoliväli J; Kontkanen O; Sweeney P; Park LC; Munoz-Sanjuan I
PLoS One; 2020; 15(12):e0243052. PubMed ID: 33370315
[TBL] [Abstract][Full Text] [Related]
2. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington's disease.
Ouk K; Aungier J; Morton AJ
Exp Neurol; 2016 Dec; 286():69-82. PubMed ID: 27646506
[TBL] [Abstract][Full Text] [Related]
3. Circadian dysfunction in the Q175 model of Huntington's disease: Network analysis.
Smarr B; Cutler T; Loh DH; Kudo T; Kuljis D; Kriegsfeld L; Ghiani CA; Colwell CS
J Neurosci Res; 2019 Dec; 97(12):1606-1623. PubMed ID: 31359503
[TBL] [Abstract][Full Text] [Related]
4. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
Yhnell E; Dunnett SB; Brooks SP
J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
[TBL] [Abstract][Full Text] [Related]
5. Corticosterone dysregulation exacerbates disease progression in the R6/2 transgenic mouse model of Huntington's disease.
Dufour BD; McBride JL
Exp Neurol; 2016 Sep; 283(Pt A):308-17. PubMed ID: 27381424
[TBL] [Abstract][Full Text] [Related]
6. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task- and protocol-dependent: influence of non-motor factors on locomotor function.
Pallier PN; Drew CJ; Morton AJ
Brain Res Bull; 2009 Mar; 78(6):347-55. PubMed ID: 19010400
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
8. Normalizing glucocorticoid levels attenuates metabolic and neuropathological symptoms in the R6/2 mouse model of huntington's disease.
Dufour BD; McBride JL
Neurobiol Dis; 2019 Jan; 121():214-229. PubMed ID: 30292559
[TBL] [Abstract][Full Text] [Related]
9. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
[TBL] [Abstract][Full Text] [Related]
10. Compromised Dopaminergic Encoding of Reward Accompanying Suppressed Willingness to Overcome High Effort Costs Is a Prominent Prodromal Characteristic of the Q175 Mouse Model of Huntington's Disease.
Covey DP; Dantrassy HM; Zlebnik NE; Gildish I; Cheer JF
J Neurosci; 2016 May; 36(18):4993-5002. PubMed ID: 27147652
[TBL] [Abstract][Full Text] [Related]
11. Alterations of striatal indirect pathway neurons precede motor deficits in two mouse models of Huntington's disease.
Sebastianutto I; Cenci MA; Fieblinger T
Neurobiol Dis; 2017 Sep; 105():117-131. PubMed ID: 28578004
[TBL] [Abstract][Full Text] [Related]
12. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effects of Anthocyanins and Environmental Enrichment in R6/1 Huntington's Disease Mice.
Kreilaus F; Spiro AS; Hannan AJ; Garner B; Jenner AM
J Huntingtons Dis; 2016 Oct; 5(3):285-296. PubMed ID: 27567888
[TBL] [Abstract][Full Text] [Related]
14. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease.
Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR
Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107
[TBL] [Abstract][Full Text] [Related]
15. Motor Assessment in Huntington's Disease Mice.
Dunnett SB; Brooks SP
Methods Mol Biol; 2018; 1780():121-141. PubMed ID: 29856017
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of progressive motor deficits in whisker movements in R6/2, Q175 and Hdh knock-in mouse models of Huntington's disease.
Garland H; Wood NI; Skillings EA; Detloff PJ; Morton AJ; Grant RA
J Neurosci Methods; 2018 Apr; 300():103-111. PubMed ID: 28472678
[TBL] [Abstract][Full Text] [Related]
17. Activation of NPY-Y2 receptors ameliorates disease pathology in the R6/2 mouse and PC12 cell models of Huntington's disease.
Fatoba O; Kloster E; Reick C; Saft C; Gold R; Epplen JT; Arning L; Ellrichmann G
Exp Neurol; 2018 Apr; 302():112-128. PubMed ID: 29309751
[TBL] [Abstract][Full Text] [Related]
18. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG
Stefanko DP; Shah VD; Yamasaki WK; Petzinger GM; Jakowec MW
Neurobiol Dis; 2017 Sep; 105():15-32. PubMed ID: 28502806
[TBL] [Abstract][Full Text] [Related]
19. Hair dysmorphology in the R6/1 and R6/2 mouse models of Huntington's disease.
Pierzynowska K; Podlacha M; Łuszczek D; Rintz E; Gaffke L; Szczudło Z; Tomczyk M; Smoleński RT; Węgrzyn G
Gene; 2021 Jan; 765():145133. PubMed ID: 32898606
[TBL] [Abstract][Full Text] [Related]
20. Degeneration of ipRGCs in Mouse Models of Huntington's Disease Disrupts Non-Image-Forming Behaviors Before Motor Impairment.
Lin MS; Liao PY; Chen HM; Chang CP; Chen SK; Chern Y
J Neurosci; 2019 Feb; 39(8):1505-1524. PubMed ID: 30587542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
